
Highlights
Technology delivers low cost, rapid, point-of-care diagnosis
-
Challenges
Better ways to diagnose patients and alert public health officials of impending disease outbreaks
-
Results
Early diagnosis and intervention helps improve patient outcomes, reduces costs, and could help prevent outbreaks from becoming pandemics
-
Solution
Equipping handheld micro-nuclear magnetic resonance devices with AT&T Global SIM cards facilitates medical data transmission in near real-time
AT&T Solutions
Discover a solution designed to fit your business needs
About
A shared mission to use IoT for good

About WaveGuide Corporation
WaveGuide, a Delaware corporation based in Cambridge, Massachusetts, researches and develops hand-held micronuclear magnetic resonance platform technology. WaveGuide combines proprietary molecular spectroscopy and diagnostic techniques to provide a system to allow diagnosis and analysis, even in remote settings, thereby helping to reduce costs and improve responsiveness to critical patient needs.
Your feedback will help us to improve AT&T Business so you continue to have a great experience when visiting us!
This survey is conducted by an independent company ForeSee for AT&T.